This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Makris, A Articles by Tsichlis, P N Search for Related Content PubMed PubMed Citation Articles by Makris, A Articles by Tsichlis, P N

 Previous Article  |  Next Article 

J Virol. 1993 July; 67(7): 4283-4289

Genomic organization and expression of Tpl-2 in normal cells and Moloney murine leukemia virus-induced rat T-cell lymphomas: activation by provirus insertion.

Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111.

ABSTRACT

Tpl-2 is a gene encoding a protein kinase which is primarily expressed in normal spleen, thymus, and lung tissue and is activated by provirus insertion in Moloney murine leukemia virus-induced T-cell lymphomas during the late stages of oncogenesis. Tpl-2 is composed of eight exons and spans a 35-kb genomic DNA region. The provirus integrates reproducibly in the last intron and in the same transcriptional orientation as the Tpl-2 gene. This genetic change leads to the expression of enhanced steady-state levels of a truncated Tpl-2 RNA transcript which is predicted to encode a protein with an altered C-terminal domain. Tpl-2 is transcribed from two alternating promoters, P1 and P2. The RNA transcripts originating in the two promoters harbor different 5' untranslated regions derived from the alternate noncoding exons IA and IB. Utilization of the P2 promoter, which gives rise to exon IB containing Tpl-2 RNA transcripts, was detected primarily in tumor cells. The Tpl-2 protein was expressed in COS-1 cells as an N-terminal fusion with a 12-amino-acid hemagglutinin tag. Immunoprecipitation of transfected COS-1 cell lysates with antihemagglutinin or anti-Tpl-2 antibodies, followed by incubation with [gamma-32P]ATP, confirmed that Tpl-2 possesses protein kinase activity.

This article has been cited by other articles:

• Tsatsanis, C., Vaporidi, K., Zacharioudaki, V., Androulidaki, A., Sykulev, Y., Margioris, A. N., Tsichlis, P. N. (2008). Tpl2 and ERK transduce antiproliferative T cell receptor signals and inhibit transformation of chronically stimulated T cells. Proc. Natl. Acad. Sci. USA 105: 2987-2992 [Abstract] [Full Text]  
• Choi, H. S., Kang, B. S., Shim, J.-H., Cho, Y.-Y., Choi, B. Y., Bode, A. M., Dong, Z. (2008). Cot, a novel kinase of histone H3, induces cellular transformation through up-regulation of c-fos transcriptional activity. FASEB J. 22: 113-126 [Abstract] [Full Text]  
• Das, S., Cho, J., Lambertz, I., Kelliher, M. A., Eliopoulos, A. G., Du, K., Tsichlis, P. N. (2005). Tpl2/Cot Signals Activate ERK, JNK, and NF-{kappa}B in a Cell-type and Stimulus-specific Manner. J. Biol. Chem. 280: 23748-23757 [Abstract] [Full Text]  
• Luciano, B. S., Hsu, S., Channavajhala, P. L., Lin, L.-L., Cuozzo, J. W. (2004). Phosphorylation of Threonine 290 in the Activation Loop of Tpl2/Cot Is Necessary but Not Sufficient for Kinase Activity. J. Biol. Chem. 279: 52117-52123 [Abstract] [Full Text]  
• Gandara, M. L., Lopez, P., Hernando, R., Castano, J. G., Alemany, S. (2003). The COOH-Terminal Domain of Wild-Type Cot Regulates Its Stability and Kinase Specific Activity. Mol. Cell. Biol. 23: 7377-7390 [Abstract] [Full Text]  
• Beinke, S., Deka, J., Lang, V., Belich, M. P., Walker, P. A., Howell, S., Smerdon, S. J., Gamblin, S. J., Ley, S. C. (2003). NF-{kappa}B1 p105 Negatively Regulates TPL-2 MEK Kinase Activity. Mol. Cell. Biol. 23: 4739-4752 [Abstract] [Full Text]  
• Kane, L. P., Mollenauer, M. N., Xu, Z., Turck, C. W., Weiss, A. (2002). Akt-Dependent Phosphorylation Specifically Regulates Cot Induction of NF-{kappa}B-Dependent Transcription. Mol. Cell. Biol. 22: 5962-5974 [Abstract] [Full Text]  
• Velasco-Sampayo, A., Alemany, S. (2001). p27kif Protein Levels and E2F Activity Are Targets of Cot Kinase During G1 Phase Progression in T Cells. J. Immunol. 166: 6084-6090 [Abstract] [Full Text]  
• Chiariello, M., Marinissen, M. J., Gutkind, J. S. (2000). Multiple Mitogen-Activated Protein Kinase Signaling Pathways Connect the Cot Oncoprotein to the c-jun Promoter and to Cellular Transformation. Mol. Cell. Biol. 20: 1747-1758 [Abstract] [Full Text]  
• Ballester, A., Velasco, A., Tobena, R., Alemany, S. (1998). Cot Kinase Activates Tumor Necrosis Factor-alpha Gene Expression in a Cyclosporin A-resistant Manner. J. Biol. Chem. 273: 14099-14106 [Abstract] [Full Text]  
• Tsatsanis, C., Patriotis, C., Bear, S. E., Tsichlis, P. N. (1998). The Tpl-2 protooncoprotein activates the nuclear factor of activated T cells and induces interleukin 2 expression in T cell lines. Proc. Natl. Acad. Sci. USA 95: 3827-3832 [Abstract] [Full Text]  
• Ceci, J D, Patriotis, C P, Tsatsanis, C, Makris, A M, Kovatch, R, Swing, D A, Jenkins, N A, Tsichlis, P N, Copeland, N G (1997). Tpl-2 is an oncogenic kinase that is activated by carboxy-terminal truncation.. Genes Dev. 11: 688-700 [Abstract]  
• Sanchez-Gongora, E., Lisbona, C., de Gregorio, R., Ballester, A., Calvo, V., Perez-Jurado, L., Alemany, S. (2000). COT Kinase Proto-oncogene Expression in T Cells. IMPLICATION OF THE JNK/SAPK SIGNAL TRANSDUCTION PATHWAY IN COT PROMOTER ACTIVATION. J. Biol. Chem. 275: 31379-31386 [Abstract] [Full Text]